PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Acute or Delayed Treatment with Anatabine Improves Spatial Memory and Reduces Pathological Sequelae at Late Time-Points after Repetitive Mild Traumatic Brain Injury.

Mouse / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27889957 ↗2017Reported benefit

Acute or Delayed Treatment with Anatabine Improves Spatial Memory and Reduces Pathological Sequelae at Late Time-Points after Repetitive Mild Traumatic Brain Injury.

MouseTBIClosed-head / concussionC57BL/6 (per indexing terms)Male (per indexing terms)Oral, delivered continuously in drinking waterTreatment started 30 min after injury; a delayed arm was created by crossover a…

Model: Repetitive mild traumatic brain injury: five midline impacts at 5 m/s, 1 mm strike depth, 200 ms dwell time, at 48 h intervals

Both early and delayed anatabine treatment improved spatial memory and reduced astroglial and microglial responses at late time points after repetitive mild traumatic brain injury.

Extraction: extract · Subtype source: review · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.